Analyst firms · BTIG · MGNX
BTIG MGNX price target and rating history
MacroGenics Inc. (MGNX) · Health Care
BTIG rates MacroGenics Inc. (MGNX) Neutral with a $24 price target, as of its latest action on Aug 1, 2024. It has published 3 rating actions on MGNX since October 2021, including 0 upgrades and 1 downgrade.
- Current rating
- Neutral
- Price target
- $24
- Median target, all firms
- Too few
- Actions on MGNX
- 3
BTIG price target on MGNX
Every BTIG rating on MGNX
- Aug 1, 2024DowngradeBTIG downgrades to Neutral from Buy
- Mar 4, 2024
- Oct 15, 2021
Questions about BTIG and MGNX
- What is BTIG's price target for MGNX?
- BTIG's latest stated price target for MacroGenics Inc. (MGNX) is $24, from its action on Mar 4, 2024.
- What is BTIG's rating on MGNX?
- BTIG rates MGNX Neutral, a neutral rating, as of Aug 1, 2024.
- When did BTIG last change its view on MGNX?
- On Aug 1, 2024, BTIG downgrades to Neutral from Buy.
More MGNX rating histories
All BTIG ratingsMGNX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.